Inactive Instrument

Highlights CS MEDICA A/S

Stocks

CSMED

DK0061668225

Highlights

May. 18	CS Medica A/S Revises Revenue Guidance for the Year 2025-2026	CI
Jan. 21	CS Medica A/S Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
Nov. 30	CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2025	CI
Nov. 30	CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
Nov. 30	CS Medica A/S Provides Revenue Guidance for the Fourth Quarter of 2025	CI
25-05-17	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
25-03-31	CS Medica A/S Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
25-01-09	Ahead of delisting: CS Medica temporarily suspends all non-revenue generating activities	FW
25-01-07	CS Medica has signed white label partnership for launch in Italy	FW
25-01-06	CS Medica Unit Secures Partnership Deal in Italy	MT
24-12-19	CS Medica company has made first delivery to Iraq	FW
24-12-02	CS Medica increases turnover and operating profit	FW
24-11-30	CS Medica A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	CI
24-11-30	CS Medica A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	CI
24-11-22	CS Medica welcomes proposal to make medical cannabis pilot program permanent	FW
24-11-12	CS Medica explains strategic motives behind Cannordic IPO / capital increase	FW
24-11-11	CS Medica Unit Signs Distribution Deal With Ukraine's Deutsch-Pharm	MT
24-11-11	CS Medica signs agreement in Ukraine with a sales potential of DKK 0.75 million	FW
24-11-04	Nuways initiates coverage of CS Medica with buy recommendation (update)	FW
24-11-04	Nuways initiates coverage of CS Medica with a buy recommendation	FW
24-09-30	Denmark's CS Medica, Germany's Nimbus Health Team Up for Medical Cannabis Therapies	MT
24-09-30	CS Medica subsidiary Cannordic starts collaboration with Nimbus Health in Germany	FW
24-09-27	CS Medica values subsidiary Cannordic at € 30 million for listing in Germany	FW
24-09-18	CS Medica in strategic partnership with Scan MedPartners - wants to expand presence in the US	FW
24-09-17	CS Medica A/S Announces Approval of CANNASEN Pain Patch in Malaysia and Trademark Registration in Thailand	CI